NEXIMMUNE INC (NEXI)
US65344D2080 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to NEXI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.04. This target is -37.42% below the current price.
NEXI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about NEXI.
In the previous month the buy percentage consensus was at a similar level.
NEXI was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-16 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2022-11-15 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2022-08-16 | Barclays | Maintains | Overweight |
| 2022-08-16 | Raymond James | Maintains | Outperform |
| 2022-06-01 | BTIG | Initiate | Buy |
| 2022-02-22 | Raymond James | Maintains | Outperform |
| 2021-11-15 | Raymond James | Maintains | Outperform |
| 2021-04-01 | Raymond James | Initiate | Outperform |
| 2021-03-09 | Cantor Fitzgerald | Initiate | Overweight |